diclofenac has been researched along with aprepitant in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Natsume, T; Ogawa, S; Takamatsu, H | 1 |
Hafez, HM; Mohamed, MZ; Rifaai, RA; Waz, S | 1 |
1 review(s) available for diclofenac and aprepitant
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for diclofenac and aprepitant
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Pharmacological profile of a novel nonhuman primate model of knee osteoarthritis].
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aprepitant; Diclofenac; Duloxetine Hydrochloride; Knee Joint; Morphine; Neurokinin-1 Receptor Antagonists; Osteoarthritis, Knee; Pain; Primates; Serotonin and Noradrenaline Reuptake Inhibitors | 2018 |
Involvement of NOX-4/JAK/STAT pathway in the protective effect of aprepitant against diclofenac-induced renal toxicity.
Topics: Animals; Aprepitant; Cyclooxygenase Inhibitors; Diclofenac; Gene Expression Regulation; Janus Kinase 1; Male; NADPH Oxidase 4; Neurokinin-1 Receptor Antagonists; Protective Agents; Rats; Rats, Wistar; Renal Insufficiency; STAT3 Transcription Factor | 2022 |